Editas Medicine Announces In Vivo Proof-Of-Concept Data For EDIT-301, In Development For The Treatment Of Sickle Cell Disease And Beta-Thalassemia

by bizlift | Dec 9, 2019 | Editas Press Releases, Portfolio News

Syneos Health and AiCure Announce partnership to Optimize Patient Engagement and Trial Success

by bizlift | Nov 12, 2019 | AiCure Press Releases, Portfolio News

Editas Medicine and Celgene Corp Amend Existing Collaboration

by bizlift | Nov 12, 2019 | Editas Press Releases, Portfolio News

Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery

by bizlift | Nov 8, 2019 | Portfolio News, Twist Press Releases

AiCure Raises $24.5 Million Series C Round to Broaden its Strategic Value for Life Sciences

by bizlift | Nov 7, 2019 | AiCure Press Releases, Portfolio News

eGenesis Announces $100M Series B Financing

by bizlift | Nov 7, 2019 | eGenesis Press Releases, Portfolio News